-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
news
newsOn August 14, the American biotechnology company Relay announced that it will reach a strategic cooperation with me-too master EQrx to develop new anti-tumor drugs with confirmed targets on a global scale when it announced its second quarter report
Drug source analysis
Drug source analysisThis collaboration looks a bit weird
A me-too that claims to be highly innovative and a bluntly mature target.
Of course, it does not rule out that both are selling dog meat to a certain extent.
Therefore, Relay may not be willing to take too much technical risk to develop new target all-construct inhibitors, while EQrx is not willing to take too much market risk to do me-too without obvious distinction.